CIBER BBN
CIBER-BBN is a Spanish public research consortium under ISCIII that coordinates 41+ research and clinical groups across Spain in bioengineering, biomaterials, and nanomedicine. It operates the NANBIOSIS ICTS infrastructure platform and is funded by the Spanish Ministry of Science and Innovation.
- Company typePrivate
- Founded2006
- HeadquartersMadrid, Spain
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What CIBER BBN does
CIBER-BBN (Consorcio Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, M.P.) is a Spanish public research consortium operating as a thematic area within the CIBER (Centro de Investigación Biomédica en Red) network under the Instituto de Salud Carlos III (ISCIII). Its mission is to promote and connect biomedical research in three areas: Bioengineering and Medical Imaging, Biomaterials and Advanced Therapies, and Nanomedicine. The consortium coordinates 41+ research groups and clinical groups distributed across Spanish institutions, headquartered in Madrid.
The consortium's core technology infrastructure centers on NANBIOSIS, a designated Singular Scientific and Technical Infrastructure (ICTS) providing standardized biomaterial and nanomedicine production and characterization services. CIBER-BBN also operates a technology pipeline (Pipeline CIBER-BBN – Oferta Tecnológica) for technology licensing and collaborative R&D, a transversal Training and Capacity Building program, and an Internationalization Platform. Ongoing cross-CIBER joint project calls link CIBER-BBN to sister consortia in cardiovascular, infectious, neurodegenerative, hepatic, rare disease, and epidemiology domains.
CIBER-BBN is a non-profit entity with no commercial product sales. Its revenue model is institutional public funding from the Spanish Ministry of Science and Innovation through ISCIII, supplemented by competitive grants, EU structural funds, and sponsorship from industry partners (notably Boehringer Ingelheim and Fundación Sabadell). Activities are delivered through competitive grant calls, scientific forums, annual CIBER-BBN Days, Young Scientist Forums, Clinical Forums, and bilateral industry-academic collaboration forums. The consortium is governed by a Board of Directors (Consejo Rector), a Scientific Direction Committee, and an External Scientific Advisory Committee.
CIBER BBN firmographics
Firmographics- Name
- CIBER BBN
- Legal name
- CONSORCIO CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED
- Website
- https://ciber-bbn.es
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- CIBER-BBN is a Spanish public research consortium under ISCIII that coordinates 41+ research and clinical groups across Spain in bioengineering, biomaterials, and nanomedicine. It operates the NANBIOSIS ICTS infrastructure platform and is funded by the Spanish Ministry of Science and Innovation.
- Ownership category
- akta.pro rank
Where CIBER BBN is headquartered
LocationHeadquarters
- HQ city
- Madrid
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
CIBER BBN business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Revenue model
- Public Research Funding: CIBER-BBN is a public consortium primarily funded by the Instituto de Salud Carlos III (ISCIII) and the Spanish Ministry of Science and Innovation. The consortium receives institutional funding to support research groups and collaborative projects.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
CIBER BBN product offering
Product offeringCore offering
CIBER-BBN is a public Spanish research consortium that coordinates basic, translational, and clinical research in bioengineering, medical imaging, biomaterials, advanced therapies, and nanomedicine. It operates the NANBIOSIS ICTS research infrastructure platform and delivers technology transfer services, training programs, and collaborative research projects across its network of 41+ research and clinical groups distributed across Spanish institutions.
Product overview
CIBER BBN is a Spanish biomedical research consortium specializing in bioengineering, biomaterials, and nanomedicine. The consortium operates as a multi-platform research organization comprising three main research programs (Bioengineering and Medical Imaging, Biomaterials and Advanced Therapies, and Nanomedicine), supported by the NANBIOSIS ICTS infrastructure platform. The organization offers technology transfer services through its Transferencia Industrial program, maintains a technology pipeline (Pipeline CIBER-BBN), and provides training programs for researchers. The consortium functions as an integrated network of research groups across Spain rather than a single product company.
Differentiator
Problem solved
Functional benefit
Brands
- NANBIOSIS: ICTs (Singular Scientific and Technical Infrastructures) platform for nanomedicine research
Products and services
- NANBIOSIS ICTS A research infrastructure platform within NANBIOSIS ICTS that provides standardized biomaterial and nanomedicine production and advanced characterization services for biomedical researchers and industry partners.
- Bioingeniería e Imagen Médica Research program focused on bioengineering and medical imaging technologies for diagnostic and therapeutic applications, conducted by affiliated research groups across Spain.
- Biomateriales y Terapias Avanzadas Research program developing advanced biomaterials and therapeutic approaches, including regenerative medicine and advanced therapies, for medical applications.
- Nanomedicina Research program dedicated to nanotechnology-based medical treatments and drug delivery systems, supporting diagnostic and therapeutic nanomedicine applications.
- Transferencia Industrial Industrial transfer program connecting consortium research with industry through forums, transfer projects, and technology offerings for pharmaceutical, medical device, and biotech partners.
- Pipeline CIBER-BBN - Oferta Tecnológica Technology pipeline catalog showcasing the consortium's available technologies for licensing or collaboration with industry partners.
- Formación y Capacitación Training and education program offering courses and workshops on scientific communication, dissemination, and AI applications in healthcare research for researchers and young scientists.
Companies that use CIBER BBN
Customer profileSegments3 records
Ideal customer profiles2 records
CIBER BBN technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature1 record
CIBER BBN partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and moderate.
- Instituto de Salud Carlos III (ISCIII)coreCIBER-BBN is funded through ISCIII as part of the CIBER (Biomedical Research Centers) network. ISCIII provides institutional funding and coordinates national biomedical research programs.
- Ministerio de Ciencia e InnovacióncoreThe Spanish Ministry of Science and Innovation provides policy direction and funding support for CIBER-BBN as a public research consortium.
- CIBER de Enfermedades Cardiovasculares (CIBERCV)moderateJoint intramural projects program promoting collaboration between CIBER-BBN and CIBERCV researchers. Maximum 2 projects with 2-year duration.
- CIBER de Enfermedades Infecciosas (CIBERINFEC)moderateCollaborative projects call (2024, 2025) requiring participation of at least one group from each area. Maximum 35,000€ per project (17,500€ per area), 12-24 month duration.
- CIBER de Enfermedades Neurodegenerativas (CIBERNED)moderateCollaborative projects promoting research on innovative solutions for neurodegenerative diseases. Maximum 35,000€ per project, 24-month duration.
- CIBER de Enfermedades Hepáticas y Digestivas (CIBEREHD)moderateJoint collaboration projects between CIBER-BBN and CIBEREHD. Maximum 2 projects with 35,000€ funding (17,500€ per area), 12-month duration.
- CIBER de Enfermedades Raras (CIBERER)moderateNanoTER 2024 call for advanced therapies based on non-viral vectors for rare diseases. Total funding up to 200,000€, 2-year execution period.
- CIBER de Epidemiología y Salud Pública (CIBERESP)moderateMeeting for Research Excellence in Public Health 2024, organized in collaboration with CIBER-BBN.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
CIBER BBN competitors and assessment
Company assessmentDirect peers
- CIBERDEM (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas): Sibling thematic area within the CIBER network under ISCIII. Shares consortium governance and ISCIII funding model, focused on diabetes and metabolic disease research; comparable operational scale and structure to CIBER-BBN.
- CIBERCV (Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares): Sibling thematic area within the same CIBER network under ISCIII. Shares the consortium model, governance structure, and funding source as CIBER-BBN, focused on cardiovascular research — and is an active documented collaboration partner via joint intramural project calls.
- CIBERFES (Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable): Sibling thematic area within CIBER network under ISCIII. Same consortium model, ISCIII funding, and governance; focused on frailty and healthy aging research. Mentioned in CIBER-BBN data as the group directing a generative AI course applied to nursing research processes.
- CIBEREHD (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas): Sibling thematic area within CIBER network under ISCIII. Same consortium structure and funding pipeline; collaborates with CIBER-BBN on joint intramural projects (up to €35k, 12-month duration) bridging biomaterials/nanomedicine with hepatic and digestive disease research.
- CIBERNED (Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas): Sibling thematic area within CIBER network under ISCIII. Shares organizational structure, funding model, and governance; collaborates with CIBER-BBN on joint projects for innovative neurodegenerative disease solutions (up to €35k per project).
- CIBERINFEC (Centro de Investigación Biomédica en Red de Enfermedades Infecciosas): Sibling thematic area within CIBER network under ISCIII. Operates the same consortium model and collaborates with CIBER-BBN through joint project calls (2024, 2025) at up to €35k per project requiring cross-area participation.
- CIBERER (Centro de Investigación Biomédica en Red de Enfermedades Raras): Sibling thematic area within CIBER network under ISCIII. Operates the same consortium model and partners with CIBER-BBN on the NanoTER advanced therapies call (up to €200k) for rare diseases, making it a direct structural and operational peer.
- CIBERSAM (Centro de Investigación Biomédica en Red de Salud Mental): Sibling thematic area within CIBER network under ISCIII. Operates the same consortium model and institutional framework; comparable scale and structure to CIBER-BBN but focused on mental health research.
- CIBERESP (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública): Sibling thematic area within CIBER network under ISCIII. Same institutional structure and funding source; collaborates with CIBER-BBN on the Meeting for Research Excellence in Public Health 2024, demonstrating cross-consortium engagement.
- CIBEROBN (Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición): Sibling thematic area within CIBER network under ISCIII. Same consortium organizational structure and public funding model; operates with comparable group network structure focused on obesity and nutrition research.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
CIBER BBN social profiles
Digital presenceCIBER BBN financial estimates
Financial estimateRevenue estimate
Valuation estimate
CIBER BBN leadership team
Management profileNumber of profiles
CIBER BBN funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CIBER BBN M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CIBER BBN
What does CIBER BBN do?
CIBER-BBN is a public Spanish research consortium that coordinates basic, translational, and clinical research in bioengineering, medical imaging, biomaterials, advanced therapies, and nanomedicine. It operates the NANBIOSIS ICTS research infrastructure platform and delivers technology transfer services, training programs, and collaborative research projects across its network of 41+ research and clinical groups distributed across Spanish institutions.
Is CIBER BBN a public or private company?
CIBER BBN is a private company. It is classified as state government owned and is currently operating.
When was CIBER BBN founded?
CIBER BBN was founded in 2006. It employs 501 to 1,000 people.
Where is CIBER BBN based?
CIBER BBN is headquartered in Madrid, Spain, in the Europe region.
How does CIBER BBN make money?
One revenue line is on record: public Research Funding.
Who are CIBER BBN's main competitors?
Direct peers on record are CIBERDEM (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas), CIBERCV (Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares), CIBERFES (Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable), CIBEREHD (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), CIBERNED (Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas), CIBERINFEC (Centro de Investigación Biomédica en Red de Enfermedades Infecciosas), CIBERER (Centro de Investigación Biomédica en Red de Enfermedades Raras), CIBERSAM (Centro de Investigación Biomédica en Red de Salud Mental), CIBERESP (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) and CIBEROBN (Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición).
Does CIBER BBN have an API?
No public API is recorded for CIBER BBN.